当前位置: X-MOL 学术Neoplasia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1
Neoplasia ( IF 4.8 ) Pub Date : 2021-07-26 , DOI: 10.1016/j.neo.2021.07.004
Yihui Ma 1 , Peiyi Xia 1 , Zhengyang Wang 1 , Jingjing Xu 1 , Lan Zhang 1 , Yanan Jiang 2
Affiliation  

Protein Disulfide Isomerase Family A Member 6 (PDIA6) is an endoplasmic reticulum protein that is capable of catalyzing protein folding and disulfide bond formation. Abnormally elevated expression of PDIA6 has been reported to predict poor outcomes in various cancers. Herein, gain-of- and loss-of-function experiments were performed to investigate how PDIA6 participated in the carcinogenesis of pancreatic cancer (PC). By analyzing the protein expression of PDIA6 in 28 paired PC and para carcinoma specimens, we first found that PDIA6 expression was higher in PC samples. Both the overall survival and disease-free survival rates of PC patients with higher PDIA6 expression were poorer than those with lower PDIA6 (n = 178). Furthermore, knockdown of PDIA6 impaired the malignancies of PC cells — suppressed cell proliferation, invasion, migration, cisplatin resistance, and xenografted tumor growth. PDIA6-silenced PC cells were more sensitive to cytotoxic natural killer (NK) cells. Overexpression of PDIA6 had opposite effects on PC cells. Interestingly, COP9 signalosome subunit 5 (CSN5), a regulator of E3 ubiquitin ligases known to promote deubiquitination of its downstream targets, was demonstrated to interact with PDIA6, and its expression was increased in PC cells overexpressing PDIA6. Additionally, PDIA6 overexpression promoted deubiquitination of β-catenin and PD-L1 and subsequently upregulated their expression in PC cells. These alterations were partly reversed by CSN5 shRNA. Collectively, the above results demonstrate that PDIA6 contributes to PC progression, which may be associated with CSN5-regulated deubiquitination of β-catenin and PD-L1. Our findings suggest PDIA6 as a potential target for the treatment of PC.



中文翻译:

PDIA6通过CSN5介导的β-连环蛋白和PD-L1去泛素化促进胰腺癌进展和免疫逃逸

蛋白质二硫键异构酶家族 A 成员 6 (PDIA6) 是一种能够催化蛋白质折叠和二硫键形成的内质网蛋白质。据报道,PDIA6 的异常升高表达可预测各种癌症的不良结果。在此,进行了功能获得和功能丧失实验以研究 PDIA6 如何参与胰腺癌 (PC) 的致癌作用。通过分析 28 对 PC 和副癌标本中 PDIA6 的蛋白表达,我们首先发现 PC 样本中 PDIA6 的表达较高。PDIA6 高表达的 PC 患者的总生存率和无病生存率均低于 PDIA6 低表达的患者(n = 178)。此外,敲低 PDIA6 会损害 PC 细胞的恶性肿瘤——抑制细胞增殖、侵袭、迁移、顺铂耐药和异种移植肿瘤生长。PDIA6 沉默的 PC 细胞对细胞毒性自然杀伤 (NK) 细胞更敏感。PDIA6的过表达对PC细胞具有相反的作用。有趣的是,COP9 信号体亚基 5 (CSN5) 是一种 E3 泛素连接酶的调节剂,已知可促进其下游靶标的去泛素化,被证明与 PDIA6 相互作用,并且其在过表达 PDIA6 的 PC 细胞中的表达增加。此外,PDIA6 过表达促进了 β-catenin 和 PD-L1 的去泛素化,随后上调了它们在 PC 细胞中的表达。这些改变被 CSN5 shRNA 部分逆转。集体,上述结果表明 PDIA6 有助于 PC 进展,这可能与 CSN5 调节的 β-catenin 和 PD-L1 去泛素化有关。我们的研究结果表明 PDIA6 是治疗 PC 的潜在靶点。

更新日期:2021-07-27
down
wechat
bug